Reshma Rangwala - 02 Mar 2026 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
EVP & Chief Medical Officer
Signature
/s/ Nancy Smith as Attorney-in-Fact for Reshma Rangwala
Issuer symbol
KPTI
Transactions as of
02 Mar 2026
Net transactions value
-$47,669
Form type
4
Filing time
03 Mar 2026, 16:25:50 UTC
Previous filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rangwala Reshma EVP & Chief Medical Officer C/O KARYOPHARM THERAPEUTICS INC., 85 WELLS AVENUE, NEWTON /s/ Nancy Smith as Attorney-in-Fact for Reshma Rangwala 03 Mar 2026 0001825322

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale $47,669 -5,066 -8.2% $9.41 56,739 02 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on April 4, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.